SCHEMBL562674

SCHEMBL562674

Cc1ccccc1S(=O)(=O)C(I)I

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
RAPGEF4 Q8WZA2 1/20 0.39
LMNA P02545 1/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TP53 P04637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.38
ACHE P22303 1/20 0.38
HSD11B1 P28845 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
EDNRA P25101 1/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
MEN1 O00255 1/20 0.36
ESR1 P03372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31575071 1.00 SLC1A3 (0.39) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL7999434 0.98 SLC1A3 (0.38) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL6097627 0.80 LMNA (0.42) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL7504532 0.80 LMNA (0.42) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL27492534 0.79 LMNA (0.40) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL8742943 0.78 LMNA (0.41) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL9732243 0.78 KAT6A (0.41) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL6282158 0.77 SLC1A3 (0.41) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL28051399 0.75 SLC1A3 (0.44) SLC1A3SLC1A2SLC1A1RAPGEF4LMNA
SCHEMBL3687664 0.75 ALDH1A1 (0.44) RAPGEF4LMNAALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078296-A1 SUSTAINED-RELEASE SCALE INHIBITORS Materials Engineering and Technical Support Services (US) 2026-03-19 US claimed
WO-2024059615-A2 SUSTAINED-RELEASE SCALE INHIBITORS MATERIALS ENGINEERING AND TECHNICAL SUPPORT SERVICES CORPORATION (US) 2024-03-21 WO claimed
CN-115397927-A Protective varnish, in particular for security documents 奥贝蒂尔信托简易股份公司 2022-11-25 CN claimed
EP-1648673-B1 COMPOSITE MATERIAL HAVING THE APPEARANCE OF NATURAL STONE COSENTINO SA (ES) 2019-04-17 EP claimed
EP-2150507-B1 ANTIMICROBIAL CEMENTITIOUS COMPOSITION, METHOD AND ARTICLE MICROBAN PRODUCTS (US) 2018-04-11 EP claimed
EP-2117300-B1 AMINOALCOHOL AND BIOCIDE COMPOSITIONS FOR AQUEOUS BASED SYSTEMS ANGUS CHEMICAL (US) 2017-04-19 EP claimed
EP-3150675-A1 ANTIMICROBIAL CEMENTITIOUS COMPOSITIONS MICROBAN PRODUCTS COMPANY (US) 2017-04-05 EP claimed
EP-3135109-A1 AMINOALCOHOL AND BIOCIDE COMPOSITIONS FOR AQUEOUS BASED SYSTEMS ANGUS Chemical Company (US) 2017-03-01 EP claimed
EP-1786873-B1 ANTIMICROBIAL CEMENTITIOUS COMPOSITIONS MICROBAN PRODUCTS (US) 2016-11-16 EP claimed
US-9034929-B2 Aminoalcohol and biocide compositions for aqueous based systems ANGUS CHEMICAL COMPANY (US) 2015-05-19 US claimed
WO-2005061228-A1 ANTIMICROBIAL INSULATION MICROBAN PRODUCTS COMPANY (US) 2005-07-07 WO claimed
WO-2005049293-A2 CEMENTITIOUS SLAB PRODUCTS HAVING ANTIMICROBIAL PROPERTIES MICROBAN PRODUCTS COMPANY (US) 2005-06-02 WO claimed
US-20050106336-A1 Cementitious slab products having antimicrobial properties MICROBAN PRODUCTS COMPANY (US) 2005-05-19 US claimed
EP-1511905-A1 ANTIMICROBIAL WALLBOARD MICROBAN PRODUCTS COMPANY (US) 2005-03-09 EP claimed
WO-2005014256-A1 COMPOSITE MATERIAL HAVING THE APPEARANCE OF NATURAL STONE COSENTINO, S.A. (ES) 2005-02-17 WO claimed
US-6767647-B2 Antimicrobial wallboard MICROBAN PRODUCTS COMPANY 2004-07-27 US claimed
EP-1408928-A1 ANTIMICROBIAL MELAMINE RESIN AND PRODUCTS MADE THEREFROM MICROBAN PRODUCTS COMPANY (US) 2004-04-21 EP claimed
US-20030234068-A1 Antimicrobial Wallboard MICROBAN PRODUCTS COMPANY (US) 2003-12-25 US claimed
WO-2003104583-A1 ANTIMICROBIAL WALLBOARD MICROBAN PRODUCTS COMPANY (US) 2003-12-18 WO claimed
WO-2003009827-A1 ANTIMICROBIAL MELAMINE RESIN AND PRODUCTS MADE THEREFROM MICROBAN PRODUCTS COMPANY (US) 2003-02-06 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078296-A1 SUSTAINED-RELEASE SCALE INHIBITORS CEL, TST, CD44 SLC1A3 2035/4885SLC1A2 1593/4885SLC1A1 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.